Amarita S. Randhawa, PharmD

VP, Medical Affairs
Ambros Therapeutics, Inc
New City, New York, United States

Presentation(s):

• Pivotal phase 3 trial of neridronate in Complex Regional Pain Syndrome Type 1: CRPS-RISE study design and methodology

  Thursday, November 13, 2025
  9:19 AM - 9:27 AM CT

  Disclosure information not submitted.

• A precision medicine approach to identifying patients with Complex Regional Pain Syndrome Type 1 who may benefit from neridronate

  Thursday, November 13, 2025
  6:00 PM - 6:08 PM CT

  Disclosure information not submitted.

• Beyond Averages: Informing Clinical Decision Making in the Pharmacologic Treatment of CRPS-1 using Bayesian Network Meta-Analysis

  Friday, November 14, 2025
  10:01 AM - 10:09 AM CT

  Disclosure information not submitted.

• A retrospective cohort analysis of mobility impairments and disability in complex regional pain syndrome type 1

  Friday, November 14, 2025
  10:54 AM - 11:02 AM CT

  Disclosure information not submitted.